Research Insights on Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 is a new market research publication announced by Reportstack. This report provides an overview of Breast Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Breast Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

To access full report with TOC, please visit Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Scope

- Extensive coverage of the Breast Cancer Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Breast Cancer Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Breast Cancer Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies Mentioned

A&G Pharmaceutical Inc Abbott Diagnostics Abviva, Inc. Accelerated Medical Diagnostics Acobiom Affichem SA AIT Austrian Institute of Technology GmbH Albert-Ludwigs-Universitat Freiburg Almac Diagnostics Ltd Amarantus Bioscience Holdings Inc AngioGenex Inc Anixa Diagnostics Corporation Armune BioScience, Inc. Arno Therapeutics Inc ArtemixRx Ascendant Diagnostics, LLC Assurance Biosciences, Inc. Atossa Genetics, Inc. Aurelium BioPharma Inc. Autoimmune Technologies LLC Ayanda Biosystems SA Baylor College of Medicine BCAL Diagnostics Pty Limited Becton Dickinson and Company Biocartis SA Biocrates Life Sciences AG Biodesix Inc BioMarCare Technologies Ltd. BioMark Diagnostics Inc. BioMarker Strategies LLC bioMerieux S.A. Biomoda, Inc. Biosceptre (Aust) Pty Ltd BioSystems International Bio-Techne Corp bioTheranostics Inc BioTime Inc Caprion Biosciences Inc Cellanyx Diagnostics, Inc. CellMax Life CellXplore, Inc. Centro de Investigacion y Asistencia en Tecnologia y Diseno del Estado de Jalisco Cepheid Ceres Nanosciences Inc Cernostics Inc. China Sky One Medical Inc Chronix Biomedical Inc Clarient Inc Cleveland Diagnostics Inc. CompanDX Ltd. Courtagen Life Sciences Inc CS-Keys, Inc. Da An Gene Co Ltd Dana-Farber Cancer Institute Inc Dartmouth College Diaxonhit SA Dublin City University Emergence BioScreening, LLC Eventus Diagnostics Inc Exiqon A/S Exosomics Siena SpA Fahy Gurteen UK Ltd Fina Biotech Fluxion Biosciences, Inc. Fournira Optime Diagnostics French National Institute of Health and Medical Research GeneNews Ltd Genentech Inc GenomicTree Inc Genoptix Inc George Washington University German Cancer Research Center Ghent University GlycoZym H. Lee Moffitt Cancer Center & Research Institute Inc Hai Kang Life Corp Ltd Health Discovery Corp Hebrew University of Jerusalem Heragen, Inc. Hummingbird Diagnostics GmbH Ikonisys Inc IncellDx Inc Innovative Health Diagnostics Insight Genetics Inc Institute of Cancer Research Inverness Medical Canada Inc. IRIS International, Inc. ITUS Corporation IV Diagnostics, Inc. John Hopkins University Jonakee Cancer Research, Inc. Kailos Genetics, Inc. Kalgene Pharmaceuticals Inc. Leica Biosystems GmbH Louisville Bioscience, Inc. MabCure Inc. Matrix-Bio, Inc. MDNA Life Sciences Inc MDxHealth SA Medical Prognosis Institute A/S MEDITE Cancer Diagnostics Inc MedMira Inc. Metabolomic Technologies Inc MetaStat Inc Milagen, Inc. MiRXES Pte Ltd Molecular Warehouse Ltd Myriad Genetics Inc NanoString Technologies Inc National University of Ireland, Galway New York University Newcastle University Novel Bio-spectrum Technologies, Inc. Nuclea Biotechnologies Inc. Nuvera Biosciences Inc Olink Proteomics AB Olympia Diagnostics, Inc Onconome, Inc. OncoStem Diagnostics Pvt. Ltd OncoVista Innovative Therapies Inc On-Q-ity, Inc. Orion Genomics LLC OTraces Inc. Oxford Impedance Diagnostics Ltd PeriRx LLC Power3 Medical Products, Inc. Precision Biologics Inc PreMD Inc Princeton University Proplex Technologies Llc Protagen AG Proteome Sciences Plc Proteomika Provista Diagnostics Inc. Qiagen NV Quest Diagnostics Inc Rna Diagnostics Inc. Roche Diagnostics International Ltd Rosetta Genomics Ltd Royal College of Surgeons in Ireland RWTH Aachen University Savicell Diagnostic Ltd. Selventa Inc Sengenics International Pte Ltd Siamab Therapeutics Inc Siemens Healthcare GmbH Soricimed Biopharma Inc Target Discovery, Inc. Taxor Diagnostics, LLC TechnoGenesys, Inc. The University of Texas MD Anderson Cancer Center Todos Medical Trinity College Dublin Universal Diagnostics, S. L. Universite De Lyon University of Alberta University of Bonn University of California Riverside University of California San Diego University of Chicago University of Colorado University of Iowa University of Maryland, Baltimore University of Nebraska University of Oxford University of South Florida University of Wisconsin Madison US Biomarkers Inc Vermillion Inc Viomics Inc. Vitatex Inc. Vitruvian Biomedical, Inc. VolitionRX Ltd XEPTAGEN SpA Xiamen Zeesan Biotech Co.,Ltd Zetiq Technologies Ltd

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

Reportstack Market Research

###